A Queens Medical Center trial found a 15-minute decrease in PACU stay when nauseated patients used QueaseEASE®, as well as a 37% decrease in Phenergan use and more than a 50% decrease of Kytril administration. In addition, 82% of patients felt that QueaseEASE® helped relieve their nausea.
AUTHOR(S): Wendy Hunter, RN, Queen’s Medical Center
DATE: July 2012
READ THE FULL STUDY BELOW:
PRODUCT EVALUATION PURPOSE
To determine if the product is clinically acceptable.
There was a 15-minute decrease in PACU Phase I time with the use of QueaseEASE® as well as a 37% decrease in Phenergan use and over 50% decrease in Kytril use.
82% of patients felt that the QueaseEASE® tabs helped relieve their nausea.